WisdomTree BioRevolution Fund (BATS:WDNA) Stock Price Up 1.4% – Should You Buy?

Posted by Teresa Graham on Aug 7th, 2026

WisdomTree BioRevolution Fund (BATS:WDNA – Get Free Report) shot up 1.4% on Wednesday . The company traded as high as $20.22 and last traded at $20.22. 653 shares were traded during trading, a decline of 31% from the average session volume of 946 shares. The stock had previously closed at $19.95.

WisdomTree BioRevolution Fund Price Performance

The business has a 50-day moving average of $19.52 and a two-hundred day moving average of $18.40. The company has a market cap of $3.13 million, a P/E ratio of 17.03 and a beta of 1.01.

Institutional Trading of WisdomTree BioRevolution Fund

A hedge fund recently raised its stake in WisdomTree BioRevolution Fund stock. Flow Traders U.S. LLC lifted its position in WisdomTree BioRevolution Fund (BATS:WDNA – Free Report) by 59.0% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 26,182 shares of the company’s stock after buying an additional 9,720 shares during the period. Flow Traders U.S. LLC owned approximately 17.45% of WisdomTree BioRevolution Fund worth $416,000 as of its most recent SEC filing.

About WisdomTree BioRevolution Fund

(Get Free Report)

The WisdomTree BioRevolution Fund (WDNA) is an exchange-traded fund that is based on the WisdomTree BioRevolution index. The fund tracks a modified equally-weighted index of companies in developed markets that focus on the advancements in genetics and biotechnology. WDNA was launched on Jun 3, 2021 and is managed by WisdomTree.